Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Acadia Pharmaceuticals Inc ACAD Jun 21, 2017 29.27 +3.72   
 Acasti Pharma Inc ACST Jun 21, 2017 1.26 -2.33   
 Accelerate Diagnostics Inc AXDX Jun 21, 2017 29.55 +4.60   
 Acceleron Pharma Inc XLRN Jun 21, 2017 32.43 +3.51   
 Access National Corp ANCX Jun 21, 2017 26.39 -2.73   
 Accuray Incorporated ARAY Jun 21, 2017 4.45 0.00   
 Acelrx Pharmaceuticals ACRX Jun 21, 2017 2.50 0.00   
 Aceto Corp ACET Jun 21, 2017 14.87 -0.80   
 Achaogen, Inc. AKAO Jun 21, 2017 23.40 +4.42   
 Achillion Pharmaceuticals ACHN Jun 21, 2017 4.23 -6.21   
 Aci Worldwide ACIW Jun 21, 2017 22.77 +1.11   
 Aclaris Therapeutics, Inc. ACRS Jun 21, 2017 26.23 +0.65   
 Acnb Corp ACNB Jun 21, 2017 29.10 0.00   
 Acorda Therapeutics ACOR Jun 21, 2017 18.70 +3.03   
 Acorn Energy ACFN Jun 21, 2017 0.26 -3.70   
 Active Alts Contrarian ETF SQZZ Jun 21, 2017 24.78 0.00   
 Activision Blizzard Inc ATVI Jun 21, 2017 60.68 +0.88   
 Actua Corporation ACTA Jun 21, 2017 14.40 +2.49   
 Acura Pharmaceuticals ACUR Jun 21, 2017 0.52 +1.96   
 ACWI Ex-US Index MSCI Ishares ACWX Jun 21, 2017 45.29 0.00   
 ACWI Index MSCI Ishares ACWI Jun 21, 2017 65.44 +0.05   
 Acxiom Corp ACXM Jun 21, 2017 25.84 -0.15   
 Adamas Pharmaceuticals, Inc. ADMS Jun 21, 2017 17.08 -0.87   
 Adamis Pharmaceuticl ADMP Jun 21, 2017 4.95 +2.59   
 Adaptimmune Therapeutics plc ADAP Jun 21, 2017 4.52 +2.73   
 Addus Homecare Corp ADUS Jun 21, 2017 36.45 -0.68   
 Addvantage Technologies Group AEY Jun 21, 2017 1.61 +0.63   
 Adesto Technologies Corporation IOTS Jun 21, 2017 4.50 +7.14   
 ADMA Biologics Inc ADMA Jun 21, 2017 3.04 +1.33   
 Adobe Systems Incorporated ADBE Jun 21, 2017 144.24 +2.36   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK